
Myeloproliferative disorders originate in the clonal expansion of a transformed pluripotential hematopoietic progenitor cell. This results in a group of syndromes that include polycythemia vera, essential thrombocythemia,

Myeloproliferative disorders originate in the clonal expansion of a transformed pluripotential hematopoietic progenitor cell. This results in a group of syndromes that include polycythemia vera, essential thrombocythemia,

Myeloproliferative disorders originate in the clonal expansion of a transformed pluripotential hematopoietic progenitor cell. This results in a group of syndromes that include polycythemia vera, essential thrombocythemia,

NEW YORK-Bone marrow ron-geur can free some patients with advanced myelofibrosis of the need for blood transfusions, Richard T. Silver, MD, clinical professor of medicine, Weill Medical College of Cornell University, said at the Chemotherapy Foundation Symposium XVIII. Dr. Silver’s major collaborators in the study were Dr. Malcolm Moore, a noted cell biologist at Memorial Sloan-Kettering Cancer Center, and Dr. Edward Athanasian, an orthopedic surgeon at the Hospital for Special Surgery, New York.